In the 2nd  PharmaBrands will bring together stakeholders from across the ecosystem to explore how rare disease teams can deliver more relevant, personalized engagement across increasingly complex patient and stakeholder journeys in 2026.

Please note: This event is for professionals employed by pharma, biotech, medtech, healthcare, or advocacy, who are working to improve outcomes in rare disease.

Special thanks to the event partner: